Mirabegron and Tacrolimus drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Mirabegron (mirabegron) and Tacrolimus (tacrolimus). Common drug interactions include pruritus among females and blood creatinine increased among males.
The phase IV clinical study analyzes what interactions people have when they take Mirabegron and Tacrolimus. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.
What is Mirabegron?
Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.
What is Tacrolimus?
Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,160 Tacrolimus users. Check the latest studies of Tacrolimus.
11 people who take Mirabegron and Tacrolimus together, and have interactions are studied.

What are the common drug interactions of Mirabegron and Tacrolimus, by gender? *:
female:
- Pruritus (severe itching of the skin)
- Conjunctivitis (pink eye)
- Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
- Blood glucose increased
- Cystitis (inflammation of the wall of the bladder)
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
- Pneumonia
- Skin disorder (skin disease)
- Skin exfoliation (removal of the oldest dead skin cells)
male:
- Blood creatinine increased
- Drug hypersensitivity
- Rash pustular (redness with pustules)
- Renal tubular atrophy (wasting of kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
- Weight increased
- Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
- Idiopathic pulmonary fibrosis (chronic lung disease)
- Inflammation
- Infusion site discomfort
What are the common drug interactions of Mirabegron and Tacrolimus, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Glomerulonephritis (a group of conditions that affect parts of the kidneys called glomeruli)
- Idiopathic pulmonary fibrosis (chronic lung disease)
- Inflammation
- Kidney fibrosis (excess fibrous connective tissue in kidney)
- Kidney transplant rejection
- Myasthenia gravis (a chronic condition that causes muscles to tire and weaken easily)
- Rash pustular (redness with pustules)
- Renal tubular atrophy (wasting of kidney tubules)
- Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
40-49:
- Conjunctivitis (pink eye)
- Dermatitis exfoliative generalised (inflammatory skin disease with erythema and scaling that affects nearly the entire cutaneous surface)
- Pruritus (severe itching of the skin)
50-59:
n/a
60+:
- Blood creatinine increased
- Blood glucose increased
- Skin disorder (skin disease)
- Skin exfoliation (removal of the oldest dead skin cells)
- Weight increased
- Cystitis (inflammation of the wall of the bladder)
- Drug hypersensitivity
- Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
- Infusion site discomfort
- Infusion site haemorrhage (bleeding from infusion site)
What are the existing conditions these people have? *
- Dermatitis Atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder): 4 people, 36.36%
- Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 18.18%
- Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 9.09%
- Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 1 person, 9.09%
- Back Pain: 1 person, 9.09%
- Cardiac Failure: 1 person, 9.09%
- Constipation: 1 person, 9.09%
- Dementia (madness): 1 person, 9.09%
- Fever: 1 person, 9.09%
- Helicobacter Gastritis (inflammation of the inner lining of the stomach caused by helicobacter pylori (h. pylori) a bacterium): 1 person, 9.09%
* Approximation only. Some reports may have incomplete information.
Do you take Mirabegron and Tacrolimus?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Mirabegron (5,414 reports)
- Tacrolimus (116,160 reports)
Browse all drug interactions of Mirabegron and Tacrolimus:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Mirabegron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Tacrolimus:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Mirabegron and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tacrolimus and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on mirabegron and tacrolimus (the active ingredients of Mirabegron and Tacrolimus, respectively), and Mirabegron and Tacrolimus (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Crestor cause Ageusia? - 15 seconds ago
- Could Kenalog cause Skin Swelling? - 15 seconds ago
- Could Rasilez cause Dermatitis? - 37 seconds ago
- Could Capecitabine cause Oral Mucosal Blistering? - 44 seconds ago
- Doxazosin Mesylate vs. Vitamin D, side effect and effectiveness comparison - 53 seconds ago
- Drug interactions of Alphagan P and Cod Liver Oil - 55 seconds ago
- Could Methotrexate Sodium cause Memory Loss? - a minute ago
- Drug interactions of Cefpodoxime Proxetil and Rocephin - a minute ago
- Drug interactions of Jakafi and Vitamin K - a minute ago
- Drug interactions of Sorafenib and Lactulose - 2 minutes ago